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Abstract
Background: Diarrhoeal diseases constitute a major public health problem, particularly in the
developing world, where the rate of mortality and morbidity is very high. The purpose of this study
was to conduct a 2 years and 3 months study in order to determine the prevalence of five
enteropathogen diarrheogenic agents in Mexico City.
Methods: Faecal samples were obtained from 300 Mexican children diagnosed as positive for
diarrhoea, aged > 2 to < 12 years old, and from 80 children matched for age but with no symptoms
of the disease (control group). Two multiplex PCR were used to detect Escherichia coli, Salmonella
spp., and Shigella spp. In addition, the two protozoan parasites Entamoeba histolytica/Entamoeba
dispar and Giardia intestinalis were detected by conventional methods.
Results:  All diarrhoeal samples were positive for one or more enteropathogens. The most
common enteropathogens in diarrhoeal samples were E. histolytica/E. dispar (70.3%), Salmonella
(ohio 28.3%; typhimurium 16.3%; infantis 8%; anatum 0.6%; Newport 0.3%), G. intestinalis (33%), E. coli
(ETEC 13.3%; EPEC 9.3%; VTEC 8.6%; EIEC 1%) and Shigella  spp. (flexneri  1.6%,  sonnei  1%).
Infections by two (24%) three (16%) and four (12%) pathogens were observed.
Conclusion: This study revealed that 52% of the patients were infected by more than one
enteropathogen, notably E. histolitica/E. dispar and Salmonella ohio. These results are useful for
clinicians to improve the empiric treatment used in such cases.
Background
Diarrhoeal diseases constitute a major public health prob-
lem, particularly in the developing world, where the rate
of mortality and morbidity is very high [1]. The World
Health Organization (WHO) has estimated that 1.5 bil-
lion episodes of diarrhoea occur every year in developing
countries, resulting in 3 million deaths [2]. In Mexico, a
governmental study conducted in the year 2003 reported
4556 cases caused by intestinal infectious [3]. The etiolog-
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ical agents of diarrhoea described in epidemiological
studies are transmitted as waterborne and foodborne.
Some foodborne pathogens have been recently consid-
ered as emerging diseases [4], despite the fact they have
been known since a long time ago. For example, out-
breaks of salmonellosis have been described for many
decades, and yet their incidence have increased over the
last 25 years. Diarrhoeal infections can be caused by many
etiological agents, but mainly by enterobacteria such as
Escherichia coli, Salmonella spp.,  Shigella  spp.,  Campylo-
bacter jejuni and Vibrio cholerae; as well as parasites such as
Entamoeba histolytica and  Giardia intestinalis, and some
rotaviruses are also important agents [5].
Escherichia coli is considered as the etiological agent for
many diseases including some affecting the urinary tract
and intestine. The classification of diarrhoegenic E. coli
strains is based on their virulence properties, and com-
prises six groups: Enterotoxigenic E. coli (ETEC), Enter-
opathogenic E. coli (EPEC), Enteroinvasive E. coli (EIEC),
Enterohaemorragic E. coli (EHEC), Enteroaggregative E.
coli (EAggEC) and Diffuse Adhering E. coli (DAEC) [6].
Salmonella spp. is a facultative, gram negative, flagellated
member of the Enterobacteriaceae family. The most exten-
sive accepted classification of Salmonella strains is based
on the diversity of two differentially expressed H flagellar
antigens: flagellin phase I and phase II antigens (codified
by fliC and fljB genes), and the O antigens of the bacterial
lipopolysaccharide, both determined by serotyping [7].
Until now, 2501 serotypes have been described [8]; which
turns Salmonella classification into a complex and labori-
ous process in the clinical laboratory; therefore, several
PCR based methods have recently been developed, and
were reported to be a simple, highly sensitive, fast and
reliable alternative when compared to traditional clinical
laboratory methods [9,10].
Shigella is a Gram negative, non-motile, rod-shaped bacte-
ria, closely related to E. coli and Salmonella, and it is the eti-
ological agent of human shigellosis and dysentery, which
is characterized by severe diarrhoea with the presence of
blood in the faeces. Classification of Shigella is based on
serotyping, and comprise the following groups and sero-
types: Serogroup A (S. dysenteriae) 12 serotypes, serogroup
B (S. flexneri) 6 serotypes, serogroup C (S. boydii) 23 sero-
types and serogroup D (S. sonnei) with only one serotype
[11].
Diarrhoea can also be caused by protozoa such as Enta-
moeba histolytica and  Giardia intestinalis, these zoonotic
parasites are frequently transmitted by consumption of
water contaminated with infective cysts [12].
The purpose of this study was to determine the prevalence
of five enteropathogen diarrheogenic agents namely E.
coli, Salmonella spp., Shigella spp., E. histolytica/E. dispar
and Giardia intestinalis in Mexico City. Stool specimens
obtained from children patients from several communi-
ties in Mexico City were examined; the association pat-
terns between different pathogens and its correlation with
occurrence of diarrhoea were also described.
Materials and methods
Stool samples
A total of 300 stool samples were obtained from children
patients with diarrhoea from different hospitals in Mexico
City (patient group); also, 80 samples were obtained from
children attending schools in the surrounding area, who
did not had diarrhoea in the previous 45 days (control
group). All subjects aged > 2 to < 12 years, and samples
were collected from September 2004 through December
2006.
The selection criteria for inclusion of children patients
with diarrhoea was having at least 3 or more soft, semi-
solid or liquid bloody faeces within 24 hours. Also, selec-
tion was made on the basis of a questionnaire filled up by
all subjects with assistance of a relative over 18 years old,
providing information regarding other gastrointestinal
disorders, non-related diseases, travelling, frequency of
diarrhoeal episodes, previous and current antibiotic treat-
ment; as well as general data such as age, gender and place
of residence. The control and patient groups were
matched for age and sex.
Bacteriology
Stool samples were streaked on the surface of MacConkey
agar (DIBICO, Mexico) for obtaining E. coli isolates and
on sodium deoxycholate agar for the selection of Shigella
and Salmonella, and were incubated overnight at 37°C. All
samples were tested for Shigella by using colony morphol-
ogy, biochemical properties, and agglutination with spe-
cific antisera (Serobac, BioRad).
Multiplex PCR assays for the detection of E. coli and Shig-
ella spp. were performed following a previously reported
method [13], which selectively amplifies specific regions
of several virulence genes: ETEC (eltB 322 bp, and estA 147
bp) VTEC (eaeA 376 bp, vt1 130 bp, and vt2 298 bp),
EPEC (eaeA 376 bp, and bfpA 367 bp) EIEC (ial 320 bp),
E. coli O157:H7 (fliC H7 625 bp, and O157, 500 bp)
present in diarrhoegenic E. coli; however, although this
method is also capable of detecting Shigella spp., it can not
distinguish it from EIEC, since the amplification target
used by this method is a region of the invasion-associated
locus (ial), common to both species. Therefore, the pres-
ence of Shigella spp. was also confirmed by using specific
antisera.Annals of Clinical Microbiology and Antimicrobials 2007, 6:17 http://www.ann-clinmicrob.com/content/6/1/17
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In order to molecularly serotype Salmonella spp., we used
two previously described methods [9,10], which makes
use of the ability of Salmonella  spp. to differentially
express fliC gene (phase I) and fljB (phase II) flagellar H
antigens, allowing the identification of the corresponding
DNA variable internal regions (H:i, H:r, H:I, v, H:e, h,
H:z10, H:b, H:d, for phase I; and H:1,2, H:1,5, H:1,6,
H:1,7, H:I, w, H:e, n, x and H:e, n, z15 for phase II).
Positive controls containing template DNA of the follow-
ing reference strains were used in every amplification
round: ETEC ATCC 35401; EPEC ATCC 43887, EHEC
ATCC 43890, EHEC ATCC 43889, EIEC ATCC 43893, E.
coli  ATCC 11775 (negative control without virulence
genes), Salmonella typhimurium, Salmonella paratyphi B and
Salmonella infantis. All primers used were obtained from
Sigma Genosys (Sigma). Gel electrophoresis was photo-
documented using a Gel Logic 100 Imaging system
(KODAK). Molecular sizing of the amplicons was per-
formed using KODAK Molecular Imaging Software.
Parasitology
Determination of E. histolytica/E. dispar and G.intestinalis
was done using Faust method. Protozoa were concen-
trated by centrifugal-floatation (500 × g 2 min) using zinc
sulphate as the diluent (specific gravity 1.19) and
observed with a light microscope at 40× [14].
Statistical methods
Differences between isolation rates among patient and
control groups were evaluated by the χ2 test.
Results
Stool samples
Sex distribution was similar in both groups: 55% of pop-
ulation were females and 45% were males. Sex distribu-
tion did not show to play an important role regarding
enteropathogen prevalence. Regarding the patient group,
58% presented abdominal pain, vomit and fever (>
39°C); and 20% required oral rehydration. Ten percent of
the stool samples obtained from this group presented
blood.
Identification of enteropathogens
In the patient group, the predominant enteropathogen
was E. histolytica/E. dispar (70.3%), followed by G. intesti-
nalis (33%), S. ohio (28.3%), S. typhimurium (16.3%) and
ETEC (13.3%); regarding the control group, E. histolytica/
E. dispar (43.7%) was also the most commonly founded
enteropathogen (Table 1), nevertheless, the prevalence of
all detected enteropathogens was significantly different (P
< 0.001).
The predominant pattern was comprised by a single enter-
opathogen infection (48%), followed by co infection
involving two pathogens (24%), and being the less com-
mon co infection by four pathogens (12%) (Table 2).
In the control group, 27.5% stool samples were free of any
of the bacterial enteropathogens analyzed, 62.5% were
positive for one and 10% were positive for two enter-
opathogens (E. histolytica/E. dispar and G. intestinalis).
Multiplex PCR and detection of Enterobacteriaceae
Only 195 E. coli strains were detected in the stool samples
(160/300 from patient group and 35/80 from control
group); 46.6 % (140/300) of cases and 56.2% (45/80) of
controls stools contain no E. coli. Analysis by multiplex
PCR shows that only 101 out of 195 E. coli were positive
(97/160, 60.6%) from patients and 4/35 (11.4%) from
control group. Eight isolates from patients were further
identified as Shigella (Table 1). The prevalence of diar-
rhoegenic E. coli in both groups was significantly different
(P < 0.001). The frequencies of the diarrhoegenic E. coli
positive for one of the targeted genes are shown in Table 3.
Table 1: Prevalence of enteropathogens among the studied populations.
Enteropathogen Patient group (%) n = 300 Control group (%) n = 80
Entamoeba histolytica/Entamoeba dispar 211 (70.3) 35 (43.7)
Giardia intestinalis 99 (33.0) 16 (20.0)
Salmonella ohio 85 (28.3) 2 (2.5)
Salmonella typhimurium 49 (16.3) 1 (1.2)
ETEC 40 (13.3) 2 (2.5)
EPEC 28 (9.3) 1 (1.2)
Salmonella infantis 24 (8.0) 0
VTEC 26 (8.6) 1(1.2)
Shigella flexneri 5 (1.6) 0
Shigella sonnei 3 (1.0) 0
EIEC 3 (1.0) 0
Salmonella anatum 2 (0.6) 0
Salmonella Newport 1 (0.3) 0
ETEC, enterotoxigenic E. coli; EPEC, enteropathogenic E. coli; VTEC, verotoxigenic E. coli; EIEC, enteroinvasive E. coli.Annals of Clinical Microbiology and Antimicrobials 2007, 6:17 http://www.ann-clinmicrob.com/content/6/1/17
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Regarding Salmonella spp., the most common species in
the patient group was S. ohio (28.3%), followed by S. typh-
imurium (16.3%) and S. infantis (8.0%); compared with S.
ohio  (2.5%) and S.  typhimurium  (1.2%) in the control
group (Table 1).
Discussion
The current study used a variety of diagnostic methods
which helped estimate 100% prevalence of the enter-
opathogens in stool samples from children presenting
diarrhoea symptoms. In addition, a high rate for multiple
infections 156/300 (52%) was observed. However, not
only the patient group had enteropathogens, also 50/80
(62.5%) members of the control group were positive for
either one or two parasites (E. histolytica/E. dispar and Gia-
rdia intestinalis). Although only 4 (5%) of the control
group were positive for diarrhoegenic E. coli (Table 3),
they did not have any symptoms by the time this study
was conducted. One of the strains detected in the controls
was E. coli O157:H7, which has been recently described as
an emerging pathogen worldwide [6,15]. The high rate of
enteropathogens detected in this study among both
groups, reflects the importance of monitoring on a daily
basis the most vulnerable population, such as low eco-
nomic level children groups.
E. histolytica/E. dispar were the most frequently found
enteropathogen in both, the patient (70.3%) and the con-
trol group (43.7%) (Table 1). Globally, amoebiasis is
wide spread in approximately 20% of the world's popula-
tion; 10% of those individuals get sick, and 0.1- 0.25% of
them die. E. histolytica constitutes the third cause of death
for parasitic diseases [16]. On the other hand, G. intestina-
lis  a protozoa which causes symptomatic infections
mainly in children under 12 years old was observed in
33% of the patient group, and 20% for the control group
(Table 1). These results are in agreement with a previous
study that reported G. intestinalis in 29.9% of a population
group in Mexico City [17]. An interesting observation is
that although 63.7% of the members of the control group
were positive for E. histolytica/E. dispar and/or G. intestina-
lis (Table 1), none of them presented symptoms of dis-
ease.
We used three multiplex PCR methods that accurately
detected specific genetic virulence markers of Salmonella
spp., Shigella spp., and E. coli groups ETEC (eltB and estA
gene fragments), EPEC (eaeA and bfpA gene fragments),
VTEC (eaeA  and  vt1or  vt2  genes), EIEC/Shigella  (ial
region), and E. coli O157:H7 (fliC H7 flagellar antigen
and a characteristic O157:H7 DNA fragment previously
described) [18]. EIEC and Shigella  are closely related
regarding some of their virulence factors and phenotypic
properties [19,20], the multiplex PCR method employed
in this study can not be used alone for a definitive discrim-
ination between these two enteropathogens since it recog-
nizes the ial locus, which can be found in both, EIEC and
Shigella spp. Therefore, ial positive amplification isolates
were considered as positive for EIEC if they showed no
agglutination when challenged against specific antiserum
for Shigella spp. Also, because eltB and ial amplicons are
very close regarding their molecular size (322 and 320 bp
respectively) (Fig. 1), two separate PCR reactions were
done, each containing specific primers against eltB or ial
in order to avoid the overlapping of amplification prod-
ucts, that might lead to false positives.
Table 2: Association patterns of enteropathogens in patient 
group stool samples.
Four Pathogen infection n*
E. histolytica/E. dispar + G. intestinalis + S. typhimurium + ETEC LT 2
E. histolytica/E. dispar + G. intestinalis + S. ohio + EPEC 2
E. histolytica/E. dispar + G. intestinalis + S. ohio + ETEC LT 2
E. histolytica/E. dispar + G. intestinalis + S. ohio + S. typhimurium 2
G. intestinalis + S. ohio + ETEC LT-ST/S. infantis 2
E. histolytica/E. dispar + S. ohio +EPEC + S. infantis 2
E. histolytica/E. dispar + G. intestinalis + S. ohio + VTEC 2
Subjects with different associations 22
Three Pathogen Infection
E. histolytica/E. dispar + S. infantis + VETEC 2
E. histolytica+ S. typhimurium + VETEC 2
E. histolytica+ G. intestinalis + EPEC 2
E. histolytica+ S. ohio + EPEC 2
E. histolytica+ S. ohio + VETEC 2
E. histolytica+ S. ohio + S. typhimurium 2
G. intestinalis+ S. ohio + VTEC 2
E. histolytica+ S. ohio + EPEC 3
E. histolytica+ G. intestinalis+ S. typhimurium 7
E. histolytica+G. intestinalis + S. ohio 7
E. histolytica+ G. intestinalis+ S. ohio 7
Subjects with different associations 10
Two Pathogen Infection
E. histolytica/E. dispar + EPEC 2
G. intestinalis + EPEC 2
S. ohio + S. typhimurium 2
E. histolytica/E. dispar + S. anatum 2
G. intestinalis + S. typhimurium 2
E. histolytica/E. dispar + VTEC 3
E. histolytica/E. dispar + S. infantis 3
G. intestinalis + ETEC LT 3
E. histolytica/E. dispar + S. typhimurium 6
E. histolytica/E. dispar + S. ohio 14
E. histolytica/E. dispar + G. intestinalis 23
Subjects with different associations 10
*n: number of subjects positive for indicated enteropathogens; 
abbreviations are the same as indicated in Table 1.Annals of Clinical Microbiology and Antimicrobials 2007, 6:17 http://www.ann-clinmicrob.com/content/6/1/17
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Diarrhoegenic E. coli was present in 32% of the patient
group and 5% of the control group (Table 3); these data
are consistent with a previous study conducted in Hanoi,
Vietnam, where diarrhoegenic E. coli was detected by mul-
tiplex PCR, in 22.5 % of the patient group and 12% for the
control group [21]. The presence of diarrhoegenic E. coli
groups has been reported world wide and recognized as
one of the major causes of deceases involving enteropath-
ogens in children [22-26]. In Mexico and other develop-
ing countries in the world, ETEC is the most prevalent
diarrhoegenic E. coli group [27,28]. It is considered as an
important pathogen in children, especially during the first
six months, where the isolation rate ranges from 10 to
30% [29]. In this study, the presence of ETEC in the
patient group (13.3%) was the highest compared to the
other E. coli groups detected (Table 1). However, this rate
is lower than what has been reported in some parts of the
world, which reaches up to 20.7% [30,31]. It seems that,
regardless of the location, the presence of eltB  gene
(encoding thermo labile toxin) is a definitive advantage
for ETEC, since in our study, the virulence gene distribu-
tion rate for eltB was high (6.6%). The same observation
was reported by another studies conducted in Sweden
[13] and Vietnam [21], where eltB  was the most com-
monly found ETEC virulence gene in the studied groups.
The second most commonly found diarrhoegenic E. coli
strain was EPEC (9.3%), which has been reported respon-
sible for a high rate of mortality and morbidity among
children, especially in developing countries where poor
sanitary conditions prevail [6]. For example, in countries
such as Mexico [32,33] and Brazil [34] up to 40% of diar-
rhoeal episodes in children are due to EPEC. Interestingly,
regarding virulence gene homogeneity distribution, it
seems that the situation for EPEC is not the same as for
ETEC. A higher percentage of eaeA+/bfpA- isolates (atypi-
cal strains) was found compared to eaeA +bfpA+ (typical
strains) (Table 3), which differs from others studies con-
ducted in Vietnam, where most of the isolates were eaeA
+bfpA+ [21].
VTEC E. coli, an enteropathogen distributed worldwide,
that has been more extensively studied in USA [35] and
Table 3: Diarrhoegenic E. coli identified in stool samples.
Virulence genes amplified Patient group (%) n = 300 Control group (%) n = 80
ETEC
estA 10 (3.3) 1 (1.2)
eltB 20 (6.6) 1 (1.2)
estA + eltB 10 (3.3) 0
EPEC
eaeA 23 (7.6) 1 (1.2)
eaeA + bfpA 5 (1.7) 0
VTEC
vt1 + vt2 + eaeA 17 (5.6) 1 (1.2)
vt2 + eaeA 5 (1.6) 0
vt1 + eaeA 4 (1.3) 0
EIEC
ial 3 (1.0) 0
Total 97 (32) 4(5)
χ2 represents statistical difference between both groups studied (P < 0.001). Abbreviations are the same as indicated in Table 1.
2.5% Agarose gel electrophoresis of E. coli amplicons  obtained from diarrhoeal samples (run conditions 120 V, 94  mA, 45 min.) Figure 1
2.5% Agarose gel electrophoresis of E. coli amplicons 
obtained from diarrhoeal samples (run conditions 120 V, 94 
mA, 45 min.). Lane 1: VTEC ATCC43889 and ATCC43890 
strains (positive control). Lane 2: Negative control without 
template DNA. Lane 3: EPEC ATCC43887 strain (positive 
control). Lane 4: ETEC ATCC 35401 (positive control); Lane 
5: EIEC ATCC43893 (positive control). Lane 6: E. coli 
ATCC11775 (avirulent strain, negative control). Lane 7: 
MWM 50-bp ladder. Lane 8: EPEC (patient group sample). 
Lane 9: negative sample (control group). Lane 10; negative 
sample (control group). Lane 11; VTEC (patient group sam-
ple). Lane 12; negative sample (patient group). Lane 13; EIEC 
(patient group sample). Lane 14; ETEC (patient group sam-
ple).Annals of Clinical Microbiology and Antimicrobials 2007, 6:17 http://www.ann-clinmicrob.com/content/6/1/17
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Europe [36] was also detected in this study. One strain of
VTEC was detected in the controls whereas in the patient
group it had a prevalence rate of 8.6% (26/300) (Table 1),
of which 17/26 (65.4 %) possessed vt1, vt2  and eaeA;
19.2% (5/26) possessed vt2 and eaeA and 15.3% (4/26)
vt1  and  eaeA;  being  vt1  the most abundant genotype
within this group (Table 3). These results differ from those
reported by Svenungsson et al., [13] where vt1 was in fact
the less commonly found genotype in their samples.
E. coli O157:H7 is an emergent pathogen causing the
haemolytic – uremic syndrome, and is considered as an
important foodborne source of intestinal infection caus-
ing more than 73,000 diarrhoeal episodes in the United
States every year [15,37]. We found one E. coli O157:H7
in the control group, however, no symptoms of diarrhoea
were reported by the time this study was conducted. There
is no explanation for this, but it might be possible that the
infection was in an early stage when the stool sample was
collected, or that the O157:H7 was a non-producing toxin
strain. EIEC was the least detected in the patient group
(1%) (Table 1), which is in agreement with a previous
study conducted in a surrounding area of Mexico City
where prevalence was 0.85% [28]. It has been estimated
that EIEC in developing countries including Latin Ameri-
can is rare [5,38]. The prevalence rate for Shigella sonnei
(1.6%) and Shigella flexneri (1%) in the current study was
very low (Table 1) when compared other studies [13,21].
However, in other parts of the world, several Shigella out-
breaks have been described, and the main feature is their
ability to spread in the population, due to its very low
infection doses (~10 bacterial cells per host) [19,20];
therefore, a low prevalence of cases of Shigella should not
be underestimated.
To detect Salmonella spp., two separate reactions contain-
ing primers complementary to all internal variable
regions of the fliC and fljB genes, which codifies phase I
and phase II flagellar antigens (Fig. 2), were used. Both
multiplex PCR systems have been previously tested in
hundreds of samples from different parts of the world,
and were reported to be accurate, fast and reliable alterna-
tive to other traditional diagnostic methods used in the
clinical laboratory [9,10]. In our study, both stool sample
groups showed S. ohio and S. typhimurium as the predom-
inant serovars; nevertheless, many other serovars were
present in both groups of samples in a considerable pro-
portion (Table 1), which suggest that Salmonella diversity
is more in comparison to E. coli, for which ETEC was con-
siderably predominant (Table 1). Salmonellosis is one of
the biggest challenges to public health all over the world.
In the year 2000, a study conducted in Mexico showed S.
typhimurium and S. ohio as the most and less commonly
found serotypes of Salmonella respectively [39]. This may
be related to the way the outbreak was studied, since we
focused on most common serotypes in children (age < 12
years) and not in the whole population. This study is
intended to investigate some interesting observations that
deserve further studying. The results revealed that all stool
samples from the patients and the majority of the control
group were positive for at least one enteropathogen and
that 52% of stool samples had multiple enteropathogens.
All of the 300 stool samples tested except 2 had either E.
histolytica/E. dispar or G. intestinalis and when an entero-
bacteria was present, it was most likely to be a Salmonella
serotype. In addition, only 12 out of 300 stool samples
tested E. coli presence was in association with a protozoa
in the absence of any type of Salmonella spp. (Table 2).
(A) 2.5% Agarose gel electrophoresis of Salmonella phase I  flagellar amplicons obtained from diarrhoeal samples Figure 2
(A) 2.5% Agarose gel electrophoresis of Salmonella phase I 
flagellar amplicons obtained from diarrhoeal samples. Lane 1: 
Negative control without template DNA. Lanes 2, 3, 4 10 
and 12; S. ohio (150 bp) (patient group). Lanes 5, 6 and 11; 
negative samples (patient group). Lane 7 S. typhimurium 
(patient group). Lane 8; MWM 50 bp ladder. Lane 9; S. infantis 
(patient group); Lane 11; Negative sample (patient group); 
Lane 13; Salmonella anatum (patient group). (B) 2.5% agarose 
gel electrophoresis of Salmonella phase II flagellar amplicons 
obtained from diarrhoeal samples. Lanes 1, 8 and 10, negative 
samples (patient group); Lane 2, Negative control without 
template DNA; Lane 3, Salmonella anatum (patient group); 
Lane 4, S. typhimurium (patient group); Lane 5, MWM 50 bp 
ladder; Lane 6, S. infantis (patient group); Lanes 7 and 9, S. 
ohio (patient group). For both electrophoresis, run condi-
tions were 120 V, 94 mA, 45 min.Annals of Clinical Microbiology and Antimicrobials 2007, 6:17 http://www.ann-clinmicrob.com/content/6/1/17
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It has been reported that S.  typhimurium  virulence is
enhanced when exposed to the rumen protozoa [40]; this
hypervirulent phenotype is linked to the presence of the
Salmonella genomic island SGI1 integron [41]. Also, it has
been shown that SGI1 is widely spread in other S. enterica
serovars; and although rumen possesses different proto-
zoa diversity than the parasites studied here, some Salmo-
nella  isolates from human infections have shown to
posses such island [42]. It is tempting to speculate that a
similar virulence enhancement process might occur in
human digestive trait; possibly through E. histolytica/E. dis-
par  or  G. intestinalis. Whether those Salmonella  strains
studied in this work possesses or expresses such genomic
island needs further study.
Conclusion
The study of enteropathogen associations may lead to a
better understanding of the etiology of diarrhoea, and
therefore in prescribing more suitable treatments in cases
of outbreaks. This study revealed that 52% of the patients
were infected by more than one enteropathogen, notably
E. histolitica/E. dispar and Salmonella ohio. These results are
useful for clinicians in improving the empiric treatment
used in such cases.
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